188 related articles for article (PubMed ID: 3285829)
1. Renal pharmacodynamic effects of torasemide and furosemide in normal man.
Dupont AG; Gerlo E; Van der Niepen P; Laekeman G; Piepsz A
Arzneimittelforschung; 1988 Jan; 38(1A):172-5. PubMed ID: 3285829
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of torasemide in healthy volunteers.
Lameire N; Dodion L
Arzneimittelforschung; 1988 Jan; 38(1A):167-71. PubMed ID: 3370064
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
Lesne M
Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
Mourad G; Haecker W; Mion C
Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
[TBL] [Abstract][Full Text] [Related]
6. Effects of torasemide on renal haemodynamics and function in anaesthetized dogs.
Uchida T; Hayashi K; Suzuki Y; Matsumura Y
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):497-504. PubMed ID: 1914250
[TBL] [Abstract][Full Text] [Related]
7. Diuretic action of the novel loop diuretic torasemide in the presence of angiotensin II or endothelin-1 in anaesthetized dogs.
Uchida T; Hayashi K; Kido H; Watanabe M
J Pharm Pharmacol; 1992 Jan; 44(1):39-43. PubMed ID: 1350626
[TBL] [Abstract][Full Text] [Related]
8. Renal effects of the high ceiling diuretic torasemide in rats and dogs.
Ghys A; Denef J; Delarge J; Georges A
Arzneimittelforschung; 1985; 35(10):1527-31. PubMed ID: 4074408
[TBL] [Abstract][Full Text] [Related]
9. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
[TBL] [Abstract][Full Text] [Related]
10. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
Liguori A; Casini A; Di Loreto M; Andreini I; Napoli C
Eur J Clin Pharmacol; 1999 Apr; 55(2):117-24. PubMed ID: 10335906
[TBL] [Abstract][Full Text] [Related]
11. Dose-response curve for torasemide in healthy volunteers.
Scheen AJ
Arzneimittelforschung; 1988 Jan; 38(1A):156-9. PubMed ID: 3370061
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
Kult J; Häcker W; Glocke M
Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
[TBL] [Abstract][Full Text] [Related]
13. Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide.
Delarge J
Arzneimittelforschung; 1988 Jan; 38(1A):144-50. PubMed ID: 3370058
[TBL] [Abstract][Full Text] [Related]
14. The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats.
Uechi M; Matsuoka M; Kuwajima E; Kaneko T; Yamashita K; Fukushima U; Ishikawa Y
J Vet Med Sci; 2003 Oct; 65(10):1057-61. PubMed ID: 14600341
[TBL] [Abstract][Full Text] [Related]
15. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
Herchuelz A; Derenne F; Deger F; Juvent M; Van Ganse E; Staroukine M; Verniory A; Boeynaems JM; Douchamps J
J Pharmacol Exp Ther; 1989 Mar; 248(3):1175-81. PubMed ID: 2703968
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
Dodion L; Ambroes Y; Lameire N
Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
Swärd K; Valsson F; Sellgren J; Ricksten SE
Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
[TBL] [Abstract][Full Text] [Related]
18. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics and pharmacodynamics of torasemide.
Knauf H; Mutschler E
Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
[TBL] [Abstract][Full Text] [Related]
20. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Kido H; Ohtaki Y
Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
